-
Something wrong with this record ?
New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells
V. Buľková, J. Vargová, M. Babinčák, R. Jendželovský, Z. Zdráhal, P. Roudnický, J. Košuth, P. Fedoročko
Language English Country France
Document type Journal Article
- MeSH
- ATP Binding Cassette Transporter, Subfamily G, Member 2 genetics metabolism MeSH
- Hypoxia-Inducible Factor 1, alpha Subunit metabolism MeSH
- Cell Hypoxia MeSH
- Hypoxia MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Neoplasm Proteins genetics metabolism MeSH
- Neoplasms * metabolism MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Basic Helix-Loop-Helix Transcription Factors genetics metabolism MeSH
- Side-Population Cells * pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The presence of key hypoxia regulators, namely, hypoxia-inducible factor (HIF)-1α or HIF-2α, in tumors is associated with poor patient prognosis. Hypoxia massively activates several genes, including the one encoding the BCRP transporter that proffers multidrug resistance to cancer cells through the xenobiotic efflux and is a determinant of the side population (SP) associated with cancer stem-like phenotypes. As natural medicine comes to the fore, it is instinctive to look for natural agents possessing powerful features against cancer resistance. Hypericin, a pleiotropic agent found in Hypericum plants, is a good example as it is a BCRP substrate and potential inhibitor, and an SP and HIF modulator. Here, we showed that hypericin efficiently accumulated in hypoxic cancer cells, degraded HIF-1/2α, and decreased BCRP efflux together with hypoxia, thus diminishing the SP population. On the contrary, this seemingly favorable result was accompanied by the stimulated migration of this minor population that preserved the SP phenotype. Because hypoxia unexpectedly decreased the BCRP level and SP fraction, we compared the SP and non-SP proteomes and their changes under hypoxia in the A549 cell line. We identified differences among protein groups connected to the epithelial-mesenchymal transition, although major changes were related to hypoxia, as the upregulation of many proteins, including serpin E1, PLOD2 and LOXL2, that ultimately contribute to the initiation of the metastatic cascade was detected. Altogether, this study helps in clarifying the innate and hypoxia-triggered resistance of cancer cells and highlights the ambivalent role of natural agents in the biology of these cells.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010901
- 003
- CZ-PrNML
- 005
- 20250121105244.0
- 007
- ta
- 008
- 230718e20230503fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2023.114829 $2 doi
- 035 __
- $a (PubMed)37146419
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Buľková, Viktória $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia
- 245 10
- $a New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells / $c V. Buľková, J. Vargová, M. Babinčák, R. Jendželovský, Z. Zdráhal, P. Roudnický, J. Košuth, P. Fedoročko
- 520 9_
- $a The presence of key hypoxia regulators, namely, hypoxia-inducible factor (HIF)-1α or HIF-2α, in tumors is associated with poor patient prognosis. Hypoxia massively activates several genes, including the one encoding the BCRP transporter that proffers multidrug resistance to cancer cells through the xenobiotic efflux and is a determinant of the side population (SP) associated with cancer stem-like phenotypes. As natural medicine comes to the fore, it is instinctive to look for natural agents possessing powerful features against cancer resistance. Hypericin, a pleiotropic agent found in Hypericum plants, is a good example as it is a BCRP substrate and potential inhibitor, and an SP and HIF modulator. Here, we showed that hypericin efficiently accumulated in hypoxic cancer cells, degraded HIF-1/2α, and decreased BCRP efflux together with hypoxia, thus diminishing the SP population. On the contrary, this seemingly favorable result was accompanied by the stimulated migration of this minor population that preserved the SP phenotype. Because hypoxia unexpectedly decreased the BCRP level and SP fraction, we compared the SP and non-SP proteomes and their changes under hypoxia in the A549 cell line. We identified differences among protein groups connected to the epithelial-mesenchymal transition, although major changes were related to hypoxia, as the upregulation of many proteins, including serpin E1, PLOD2 and LOXL2, that ultimately contribute to the initiation of the metastatic cascade was detected. Altogether, this study helps in clarifying the innate and hypoxia-triggered resistance of cancer cells and highlights the ambivalent role of natural agents in the biology of these cells.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a vedlejší populace buněk $x patologie $7 D058985
- 650 _2
- $a ABC transportér z rodiny G, člen 2 $x genetika $x metabolismus $7 D000070997
- 650 _2
- $a nádorové proteiny $x genetika $x metabolismus $7 D009363
- 650 _2
- $a hypoxie $7 D000860
- 650 12
- $a nádory $x metabolismus $7 D009369
- 650 _2
- $a hypoxie buňky $7 D015687
- 650 _2
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a transkripční faktory bHLH $x genetika $x metabolismus $7 D051792
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vargová, Jana $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia. Electronic address: jana.vargova@upjs.sk
- 700 1_
- $a Babinčák, Marián $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia
- 700 1_
- $a Jendželovský, Rastislav $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia
- 700 1_
- $a Zdráhal, Zbyněk $u Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
- 700 1_
- $a Roudnický, Pavel $u Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
- 700 1_
- $a Košuth, Ján $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia $7 xx0327820
- 700 1_
- $a Fedoročko, Peter $u Institute of Biology and Ecology, Department of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovakia
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy $x 1950-6007 $g Roč. 163 (20230503), s. 114829
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37146419 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20250121105241 $b ABA008
- 999 __
- $a ok $b bmc $g 1963362 $s 1197166
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 163 $c - $d 114829 $e 20230503 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20230718
